Related Experiment Video
Updated: Mar 17, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
Publications presenting negative impacts of pharmacists
A Guérin1, A Leroux1, D Lebel2
1Pharmacy Practice Research Unit, CHU Sainte-Justine, 3175, Côte-Sainte-Catherine, Montréal, Quebec, Canada.
Annales Pharmaceutiques Francaises
|August 1, 2016
Summary
Few studies (4%) report negative impacts of clinical pharmacy activities. Encouraging publication of these negative findings is crucial for a balanced understanding of pharmacy
Area of Science:
- Pharmacology
- Health Services Research
Background:
- Clinical pharmacy activities are widely studied for their positive impacts.
- However, a comprehensive understanding requires evaluating potential negative consequences.
Purpose of the Study:
- To determine the publication rate of studies indicating negative impacts of clinical pharmacy activities.
- To identify the types and origins of reported negative impacts.
Main Methods:
- A descriptive, retrospective literature review was performed.
- PubMed was searched for articles published between 2009-2014 on pharmacist roles and impacts.
- Publications with at least one negative impact indicator were identified and analyzed.
Main Results:
- Out of 203 articles reviewed, only 9 (4%) reported negative impacts.
- The majority of these negative impact studies (66%) were conducted in the United States.
- Nine distinct indicators of negative impact were identified across various study designs.
Conclusions:
- A low proportion of published literature addresses the negative impacts of clinical pharmacy.
- There is a need to encourage the publication of negative results to provide a more complete picture of clinical pharmacy's effects.
- Further research should explore both positive and negative outcomes to inform practice and policy.
Keywords:
Impact négatifIndicateursNegative impactOutcomesPharmaciensPharmacistsPublicationReviewRevueMore Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
54
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
54
01:25Pharmacokinetics: Drug–Drug Interactions
606
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
606
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
278
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
278
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
222
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
222
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
793
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
793